# Thymulin FAQ: Zinc, Mechanism, Research, and Regulatory Status

> Thymulin FAQ — direct, cited answers on what thymulin is, why it needs zinc, what the research found, how it differs from thymosin alpha-1, dosing in studies, and its regulatory status.

Straight answers to the questions people actually ask about thymulin — each one cited where it makes a quantitative claim.

## What is thymulin?

Thymulin (originally serum thymic factor, FTS) is a zinc-dependent nonapeptide hormone produced exclusively by thymic epithelial cells, biologically active only when bound to zinc [1][2]. It is studied as a research peptide and is not FDA-approved. The defining fact is its strict 1:1 zinc dependence: without bound zinc, the peptide is inactive [1].

## What is thymulin peptide?

It is the nine-amino-acid peptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn that becomes the active hormone thymulin when it binds one zinc ion [2]. The zinc-free apopeptide is inactive [2]. So 'thymulin peptide' and 'active thymulin' differ by exactly one thing: a bound zinc ion.

## Is thymulin the same as serum thymic factor (FTS)?

Yes. 'Serum thymic factor' (facteur thymique serique, FTS) is the original name; the zinc-bound, biologically active form was named thymulin (FTS-Zn) in 1982 [1]. Older papers using 'FTS' and newer ones using 'thymulin' describe the same peptide.

## What does thymulin do in the body?

Endogenously, zinc-bound thymulin participates in T-cell differentiation and immune modulation and acts as a hypophysiotropic peptide in a thymus-neuroendocrine axis [4]. These are described as physiological roles in the research literature, not treatment effects in people.

## What is the role of zinc in thymulin activity?

Thymulin is biologically active only when bound to one zinc ion per molecule, in a 1:1 ratio [1]. Chelating the zinc abolishes activity in bioassays; adding zinc back restores it [1]. The zinc-free form, apothymulin, is inactive [2].

## Why does thymulin need zinc to work?

Binding one zinc ion gives thymulin the three-dimensional conformation required for biological activity [1][2]. The zinc creates a conformational epitope, and removing zinc abolishes activity in bioassays [1]. Zinc is a precondition for thymulin's function, not just a modifier of it.

## What is the amino acid sequence of thymulin?

Thymulin is the linear nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (<Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) [2]. It adopts a specific zinc-bound conformation required for activity, and its molecular weight is about 858.86 Da [2].

## How is thymulin different from thymosin alpha-1?

Thymulin is a zinc-dependent nonapeptide whose activity requires bound zinc; thymosin alpha-1 is a different, longer thymic peptide [1][2]. They are chemically and pharmacologically distinct compounds and should not be conflated, and they do not share research data.

## What are the benefits of thymulin peptide?

Research describes anti-inflammatory, immunomodulatory, and analgesic activity in animal and in-vitro models [6][8][14]. No human benefits are established; results are framed as study findings in specific species and models, not clinical outcomes.

## What are the benefits of thymulin?

Across preclinical models, thymulin has been associated with reduced inflammatory signaling including NF-kB suppression, T-cell maturation, and lowered hyperalgesia [6][8][14]. These are research observations, not demonstrated clinical benefits in people.

## Does thymulin reduce inflammation?

In mouse models of LPS-induced and chronic inflammation, thymulin lowered pro-inflammatory cytokines and heat-shock proteins and modulated NF-kB/JNK signaling [6]. These anti-inflammatory effects are findings in animals, not in people.

## Can thymulin help with autoimmune disease?

In rodent autoimmune-encephalomyelitis (a multiple-sclerosis model) and type-1-diabetes models, thymulin reduced disease severity and inflammatory markers [10]. Early human autoimmune work used a synthetic analog (nonathymulin) in rheumatoid arthritis [4]. All remain research findings, not approved treatments.

## Is thymulin studied for pain relief?

In rodent models, thymulin and its analog PAT dose-dependently reduced inflammatory and neuropathic hyperalgesia, with no effect on baseline pain [4][14]. This is preclinical analgesia research, not a human pain treatment.

## Does thymulin boost the immune system?

In study models, thymulin drives T-cell differentiation and modulates immune-cell function; in aged mice, zinc repletion restored thymic function and partly recovered mitogen responses and NK activity [8][9]. These are research findings in animals and in vitro, not demonstrated immune benefits in people.

## Does thymulin have anti-aging effects?

Circulating thymulin peaks in childhood and declines with age in humans, and reviews link declining zinc-dependent thymulin to immunosenescence and inflammaging [11][12]. Research describes associations, not an anti-aging treatment effect.

## Is there a thymulin supplement?

There is no marketed thymulin dietary supplement. Thymulin is an endogenous zinc-dependent thymic peptide studied as a research chemical; it is not FDA-approved and is not sold as a consumer supplement [4]. Some aging research instead studies zinc repletion, which restored thymulin activity in animals [9].

## Does zinc deficiency lower thymulin levels?

Yes, in study settings. In mildly zinc-deficient adults, serum thymulin activity fell despite normal plasma zinc and was corrected by zinc repletion [3]. In aged mice, low thymulin reflected reduced peripheral zinc saturation of the peptide rather than primary thymic failure [9].

## Does thymulin decline with age?

A cross-sectional human study found that serum thymulin peaks in childhood and progressively declines from adolescence into older age [11]. Animal work shows much of the age-related decline is zinc-dependent and partly reversible with zinc supplementation [9].

## How is thymulin administered in research?

Studies have used intraperitoneal, subcutaneous, intracerebroventricular, intratracheal (gene therapy), and in-vitro routes in animals and cells [4][7][8]. These are experimental routes in research models, not human administration guidance.

## What doses of thymulin were used in animal studies?

Reported research doses range from nanograms to low micrograms per animal — for example, 0.1-1 microgram intracerebroventricularly and 1-1000 ng intraperitoneally in rodents [4][14], and 10-50 microgram subcutaneously in mice [10]. These are study findings in specified species, not protocols for human use.

## Is thymulin FDA approved?

No. Thymulin is not approved by the FDA for any indication and is handled as a research chemical for laboratory use only [4]. It is not a dietary supplement and is not an approved drug. There is no thymulin brand-name medicine.

## What is thymulin's regulatory status?

Thymulin is not a US controlled substance and is not FDA-approved for human use; it is supplied for laboratory research only [4]. It is not eligible as a compounded medication, and athletes should consult current WADA guidance for peptide hormones and immunomodulators, which are scrutinized in sport.

## How is thymulin handled and obtained for research?

Thymulin is handled as a laboratory research chemical, not a consumer product. It is not FDA-approved, not a dietary supplement, and not eligible for pharmacy compounding, so there is no prescription pathway and no compounding-pharmacy route [4]. This site is an editorial digest of the literature and does not sell, source, or supply it.

---

RX Thymulin assembles the zinc-dependent thymulin record block by block — the 1:1 zinc switch logged before any effect, the T-cell and anti-inflammatory findings snapped to their own studies, and the empty human-efficacy slot left open rather than filled; a research build console, never a clinic, a pharmacy, or a prescription.